427 related articles for article (PubMed ID: 10587518)
21. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels.
Andjelkovic AV; Pachter JS
J Neurochem; 2000 Nov; 75(5):1898-906. PubMed ID: 11032879
[TBL] [Abstract][Full Text] [Related]
22. CCR and CC chemokine expression in relation to Flt3 ligand-induced renal dendritic cell mobilization.
Coates PT; Colvin BL; Ranganathan A; Duncan FJ; Lan YY; Shufesky WJ; Zahorchak AF; Morelli AE; Thomson AW
Kidney Int; 2004 Nov; 66(5):1907-17. PubMed ID: 15496162
[TBL] [Abstract][Full Text] [Related]
23. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice.
Morteau O; Castagliuolo I; Mykoniatis A; Zacks J; Wlk M; Lu B; Pothoulakis C; Gerard NP; Gerard C
Gastroenterology; 2002 Mar; 122(3):725-33. PubMed ID: 11875005
[TBL] [Abstract][Full Text] [Related]
24. Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors.
Anders HJ; Banas B; Linde Y; Weller L; Cohen CD; Kretzler M; Martin S; Vielhauer V; Schlöndorff D; Gröne HJ
J Am Soc Nephrol; 2003 Feb; 14(2):317-26. PubMed ID: 12538732
[TBL] [Abstract][Full Text] [Related]
25. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
26. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages.
Veillard NR; Braunersreuther V; Arnaud C; Burger F; Pelli G; Steffens S; Mach F
Atherosclerosis; 2006 Sep; 188(1):51-8. PubMed ID: 16321392
[TBL] [Abstract][Full Text] [Related]
27. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
[TBL] [Abstract][Full Text] [Related]
28. Resident cell chemokine expression serves as the major mechanism for leukocyte recruitment during local inflammation.
García-Ramallo E; Marques T; Prats N; Beleta J; Kunkel SL; Godessart N
J Immunol; 2002 Dec; 169(11):6467-73. PubMed ID: 12444156
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response.
Schrum S; Probst P; Fleischer B; Zipfel PF
J Immunol; 1996 Oct; 157(8):3598-604. PubMed ID: 8871660
[TBL] [Abstract][Full Text] [Related]
30. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP-1 alpha during differentiation of human monocytes to macrophages.
Kaufmann A; Salentin R; Gemsa D; Sprenger H
J Leukoc Biol; 2001 Feb; 69(2):248-52. PubMed ID: 11272275
[TBL] [Abstract][Full Text] [Related]
31. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
[TBL] [Abstract][Full Text] [Related]
32. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.
Dorner BG; Scheffold A; Rolph MS; Huser MB; Kaufmann SH; Radbruch A; Flesch IE; Kroczek RA
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6181-6. PubMed ID: 11972057
[TBL] [Abstract][Full Text] [Related]
33. The atypical chemokine receptor 2 limits renal inflammation and fibrosis in murine progressive immune complex glomerulonephritis.
Bideak A; Blaut A; Hoppe JM; Müller MB; Federico G; Eltrich N; Gröne HJ; Locati M; Vielhauer V
Kidney Int; 2018 Apr; 93(4):826-841. PubMed ID: 29395335
[TBL] [Abstract][Full Text] [Related]
34. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
Sarau HM; Rush JA; Foley JJ; Brawner ME; Schmidt DB; White JR; Barnette MS
J Pharmacol Exp Ther; 1997 Oct; 283(1):411-8. PubMed ID: 9336350
[TBL] [Abstract][Full Text] [Related]
35. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
[TBL] [Abstract][Full Text] [Related]
36. Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-/- mice and Rag-2-/- mice reconstituted with CD4+CD45RBhigh T cells.
Scheerens H; Hessel E; de Waal-Malefyt R; Leach MW; Rennick D
Eur J Immunol; 2001 May; 31(5):1465-74. PubMed ID: 11465103
[TBL] [Abstract][Full Text] [Related]
37. Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.
Zernecke A; Weber KS; Erwig LP; Kluth DC; Schröppel B; Rees AJ; Weber C
J Immunol; 2001 May; 166(9):5755-62. PubMed ID: 11313419
[TBL] [Abstract][Full Text] [Related]
38. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.
Bonecchi R; Polentarutti N; Luini W; Borsatti A; Bernasconi S; Locati M; Power C; Proudfoot A; Wells TN; Mackay C; Mantovani A; Sozzani S
J Immunol; 1999 Jan; 162(1):474-9. PubMed ID: 9886422
[TBL] [Abstract][Full Text] [Related]
39. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis.
Anders HJ; Vielhauer V; Kretzler M; Cohen CD; Segerer S; Luckow B; Weller L; Gröne HJ; Schlöndorff D
J Am Soc Nephrol; 2001 May; 12(5):919-931. PubMed ID: 11316850
[TBL] [Abstract][Full Text] [Related]
40. Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor.
Zoffmann S; Chollet A; Galzi JL
Mol Pharmacol; 2002 Sep; 62(3):729-36. PubMed ID: 12181451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
